metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology O-12 HELICOBACTER PYLORI VIRULENCE GENES ARE ASSOCIATED WITH NAFLD SEVERITY: A C...
Información de la revista
Vol. 29. Núm. S1.
Abstracts of the 2023 Annual Meeting of the ALEH
(febrero 2024)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 29. Núm. S1.
Abstracts of the 2023 Annual Meeting of the ALEH
(febrero 2024)
Acceso a texto completo
O-12 HELICOBACTER PYLORI VIRULENCE GENES ARE ASSOCIATED WITH NAFLD SEVERITY: A CROSS SECTIONAL STUDY IN DYSPEPTIC PATIENTS
Visitas
159
Facundo Maiorana1, Maria Virginia Caronia1, Karina Elizondo1, Magali Neschuk1, Graciela Jorda1, Adolfo Schneider2, Pedro Dario Zapata3, Fernando Javier Barreyro3
1 Instituto de Biotecnología de Misiones, Universidad Nacional de Misiones, Posadas, Argentina
2 Facultad de Medicina, Fundación H.A. Barcelo, Santo Tome, Argentina
3 Instituto de Biotecnología de Misiones, Universidad Nacional de Misiones. CONICET, Posadas, Argentina
Este artículo ha recibido
Información del artículo
Suplemento especial
Este artículo forma parte de:
Vol. 29. Núm S1

Abstracts of the 2023 Annual Meeting of the ALEH

Más datos
Introduction and Objectives

Recent studies have suggested an association between Helicobacter pylori (Hpyl) and non-alcoholic fatty liver disease (NAFLD). The current study aimed to examine the association of Hpyl virulence genes and NAFLD in dyspeptic patients.

Materials and Methods

prospective multicenter study from 2019 to 2022 in northeast Argentina. We evaluated 386 dyspeptic patients who fulfilled the ROME III criteria and underwent gastroscopy. NAFLD was defined by ultrasound in the absence of other known liver diseases. cagA, vacAs1/s2, vacAm1/m2 were analyzed by PCR.

Results

The prevalence of NAFLD was 41% (156/383), no association with Hpyl status was observed. In NAFLD subjects, Hpyl+ showed higher AST (Hpyl+: 30 (21) UI/mL vs. Hpyl-: 22 (13) UI/mL, p:0,001), ALT (Hpyl+: 32 (25) UI/mL vs. Hpyl-: 25 (17) UI/mL, p: 0,0018) and FIB-4 (Hpyl+: 1,3 (1) vs. Hpyl-: 0.99 (0.6), p: 0,009). Indeed, Hpyl+ was associated with FIB-4>1,3 (Hpyl+: 54% vs. Hpyl-: 27%, p: 0,009). cagA and vacAm1 were associated with higher ALT (cagA 40 (23) UI/mL, p:0,003, vacAm1 44 (24) UI/mL, p:0,004). Also, higher FIB-4 values were observed with cagA (1,3 (0,9), p: 0,02) and vacAm1 (1.34 (0.8), p: 0,001) with more proportion of patients with FIB-4>1,3 with cagA 54% (p: 0,008) and vacAm1 55% (p: 0.007). The allelic combination vacAs1/m1+cagA showed higher AST (34 (22) UI/mL, p: 0,001), ALT (44 (24) UI/mL, p: 0,004) Fib-4 (1,34 (0,8), p:0.001) with significantly more proportion with FIB-4>1,3 (62%, p: 0,019).

Conclusions

In NAFLD/dyspeptic patients, Hpyl infection was associated with markers of liver injury and fibrosis. cag-A, vacAm1 strains and the allelic combination vacAs1/m1/cagA were associated with higher ALT and FIB-4.

El Texto completo está disponible en PDF
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos